Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Ki Hyun Bae"'
Autor:
Ki Hyun Bae, Bhuvaneshwari Shunmuganathan, Li Zhang, Andrew Lim, Rashi Gupta, Yanming Wang, Boon Lin Chua, Yang Wang, Yue Gu, Xinlei Qian, Isabelle Siang Ling Tan, Kiren Purushotorman, Paul A. MacAry, Kevin P. White, Yi Yan Yang
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract The advent of SARS-CoV-2 variants with defined mutations that augment pathogenicity and/or increase immune evasiveness continues to stimulate global efforts to improve vaccine formulation and efficacy. The extraordinary advantages of lipid n
Externí odkaz:
https://doaj.org/article/6d09a079023146a59522e73433c8c050
Autor:
Ayça Altay Benetti, Eugene Yang Zhi Tan, Zi Wei Chang, Ki Hyun Bae, Ma Thinzar Thwin, Ram Pravin Kumar Muthuramalingam, Kuo-Chieh Liao, Yue Wan, Lisa F. P. Ng, Laurent Renia, Jianping Liu, Xiaoyuan Chen, Yi Yan Yang, Kevin P. White, Giorgia Pastorin
Publikováno v:
Vaccines, Vol 12, Iss 4, p 409 (2024)
Chitosan, a natural polysaccharide derived from chitin, possesses biocompatibility, biodegradability, and mucoadhesive characteristics, making it an attractive material for the delivery of mRNA payloads to the nasal mucosa and promoting their uptake
Externí odkaz:
https://doaj.org/article/122d3c55698b4c09877564d4b6bcf986
Autor:
Ki Hyun Bae, Fritz Lai, Jamie Mong, Akiko Niibori-Nambu, Kiat Hwa Chan, Zhisheng Her, Motomi Osato, Min-Han Tan, Qingfeng Chen, Motoichi Kurisawa
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Currently available anti-leukemia drugs have shown limited success in the treatment of acute myeloid leukemia (AML) due to their poor access to bone marrow niche supporting leukemic cell proliferation. Results Herein, we report a
Externí odkaz:
https://doaj.org/article/180f891b6cc5400d85328a374f462149
Autor:
Gyeongwoo Lee, Young-Gwang Ko, Ki Hyun Bae, Motoichi Kurisawa, Oh Kyoung Kwon, Oh Hyeong Kwon
Publikováno v:
Biomaterials Research, Vol 26, Iss 1, Pp 1-16 (2022)
Abstract Background Overproduction of reactive oxygen species (ROS) is known to delay wound healing by causing oxidative tissue damage and inflammation. The green tea catechin, (–)-Epigallocatechin-3-O-gallate (EGCG), has drawn a great deal of inte
Externí odkaz:
https://doaj.org/article/514d7bad7f114c059e3c8fd8aab6f676
Publikováno v:
Polymers, Vol 16, Iss 2, p 225 (2024)
Acute myeloid leukemia carrying FMS-like tyrosine kinase receptor-3 (FLT3) mutations is a fatal blood cancer with a poor prognosis. Although the FLT3 inhibitor gilteritinib has recently been approved, it still suffers from limited efficacy and relati
Externí odkaz:
https://doaj.org/article/9b0fce78b44f4ca8bb8a7eeeae4698b3
Autor:
Gyeongwoo Lee, Young-Gwang Ko, Ki Hyun Bae, Motoichi Kurisawa, Oh Kyoung Kwon, Oh Hyeong Kwon
Publikováno v:
Biomaterials Research, Vol 27, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/4c3a4ac4d66040dea934a68da43970e5
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 381 (2022)
Chemoresistance is one of the major challenges for the treatment of acute myeloid leukemia. Epigallocatechin gallate (EGCG), a bioactive polyphenol from green tea, has attracted immense interest as a potential chemosensitizer, but its application is
Externí odkaz:
https://doaj.org/article/3992834989ba4f2f98b7f83ea6adf80a
Autor:
Ki-Hyun Bae
Publikováno v:
Journal of Current Southeast Asian Affairs; Apr2024, Vol. 43 Issue 1, p48-64, 17p
Publikováno v:
Biofunctional Materials.
Publikováno v:
Globalizations. 19:1225-1240